Comparison of nucleocapsid and spike antibody ELISAs for determining SARS‐CoV‐2 seropositivity in Kenyan women and infants

A multitude of enzyme‐linked immunosorbent assays (ELISAs) has been developed to detect severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibodies since the coronavirus disease 2019 pandemic started in late 2019. Assessing the reliability of these assays in diverse global populations is...

Descripción completa

Detalles Bibliográficos
Autores principales: Fish, Carolyn S., Owiti, Prestone, Begnel, Emily R., Itell, Hannah L., Ojee, Ednah, Adhiambo, Judith, Ogweno, Vincent, Holland, LaRinda A., Richardson, Barbra A., Khan, Adam K., Maqsood, Rabia, Gantt, Soren, Lim, Efrem S., Slyker, Jennifer, Kinuthia, John, Overbaugh, Julie, Wamalwa, Dalton, Lehman, Dara A., Chohan, Bhavna H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839577/
https://www.ncbi.nlm.nih.gov/pubmed/36251533
http://dx.doi.org/10.1002/jmv.28221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839577/
https://www.ncbi.nlm.nih.gov/pubmed/36251533
http://dx.doi.org/10.1002/jmv.28221

Ejemplares similares